S&P और Nasdaq का आंतरिक मूल्य संपर्क करें

Scinai Immunotherapeutics Ltd. SCNI NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • IL • USD

SharesGrow Score
57/100
2/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Scinai Immunotherapeutics Ltd. (SCNI) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.

विश्लेषकों का अनुमान राजस्व $0.00B अगले वित्तीय वर्ष के लिए.

EPS अनुमान — SCNI

Profitability Outlook
Company has been making losses in all recent fiscal years.

राजस्व अनुमान — SCNI

27%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2024 Actual $0.001B vs Est $0.000B ▲ 72.9% off
Revenue Trend
Analysts expect stable revenue going forward.
संपर्क करें
🎓
SharesGrow अकादमी
आंतरिक मूल्य गणना और कम मूल्य स्टॉक खोजना सीखें।
साप्ताहिक लाइव सत्र
हमें संदेश भेजें